Categories: HealthcareNews

Connecticut Proton Therapy Center selects RayCare

STOCKHOLM, Aug. 21, 2024 /PRNewswire/ — RaySearch Laboratories AB (publ) is pleased to announce that the Connecticut Proton Therapy Center, Wallingford, Connecticut, USA, has placed an order for the oncology information system RayCare®*.

The Connecticut Proton Therapy Center will be the first of its kind in the state of Connecticut and is a collaboration between Yale New Haven Health, Hartford HealthCare and Proton International. The center has selected RayCare and the IBA Proteus®ONE compact proton therapy system as its treatment platform.

RayCare will be Connecticut Proton Therapy Center’s only oncology information system and will be utilized with the ProteusONE proton system. The center will use the workflow engine of RayCare for creating clinic specific workflows, with the aim of a complete clinical implementation in 2026, when the center opens. RayCare will also be used together with RaySearch’s treatment planning system RayStation, which was acquired in 2023.

Johan Löf, founder and CEO, RaySearch, says: “We are happy to welcome yet another RayCare customer. For our installed base of RayStation customers the selection of RayCare as oncology information system will enhance efficiency and user experience, both in the treatment planning process and treatment delivery.”

Revenue from the order is expected to be recognized during 2025.

For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com

* Subject to regulatory clearance in some markets.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/raysearch-laboratories/r/connecticut-proton-therapy-center-selects-raycare,c4026538

The following files are available for download:

View original content:https://www.prnewswire.com/news-releases/connecticut-proton-therapy-center-selects-raycare-302227390.html

SOURCE RaySearch Laboratories

Staff

Recent Posts

MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi

KARACHI, Pakistan, Dec. 22, 2025 /PRNewswire/ -- MindHYVE.ai, Inc., and Khoja (Pirhai) Shia Isna Asheri Jamaat…

54 minutes ago

Castle Connolly Names Dr. Meegan Gruber, MD, PhD a 2026 Exceptional Woman in Medicine; Recognition to Be Featured in New York Magazine

Board-certified plastic surgeon and surgeon-scientist honored for clinical excellence, leadership, and commitment to patient education. …

54 minutes ago

Planning Time Off in 2026: Dr. Meegan Gruber, MD, PhD Releases a Recovery-Logistics Guide for Busy Professionals Considering Plastic Surgery

New "Recovery Logistics" checklist helps patients coordinate work, childcare, travel, and follow-up support-before they choose…

54 minutes ago

How to Choose a Plastic Surgeon in 2026: Dr. Meegan Gruber, MD, PhD Releases a Tampa Bay Patient Safety Checklist

Board-certified plastic surgeon shares a practical, question-based guide to help patients verify credentials, facility standards,…

54 minutes ago

Facelift + Eyelid Surgery in Tampa: Gruber Plastic Surgery Shares 2025 Planning Insights on Natural Results and Popular Procedure Pairings

ASPS trend reporting highlights facelift combined with eyelid surgery as a leading 2025 combination; national…

54 minutes ago

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI)…

4 hours ago